Anacor Pharmaceuticals Announces the Sale of 3.25 Million Shares of Common Stock

Anacor Pharmaceuticals

, today announced the sale of 3.25 million shares of its common stock for gross proceeds of $21,450,000 pursuant to an underwriting agreement with Canaccord Genuity acting as the sole bookrunner. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 487,500 shares of common stock to cover over-allotments, if any. The Company expects to use the net proceeds from the sale of the shares for research and development activities, working capital and general corporate purposes. Closing of the offering is expected to occur on or about February 14, 2012, subject to customary closing conditions.